These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36856276)

  • 1. Efficacy of a new nutraceutical formulation: L-tryptophan, probiotics, charcoal, chamomile, mint, and licorice (COLONIR®) in the improvement of gastrointestinal symptoms in subjects with irritable bowel syndrome.
    Fiorini G; Saracino IM; Pavoni M; Nipote B; Colucci R; Capone P; Sannino A; Forte F; DE Vergori E; Brancaccio M; Cesareo M; Casella G; Morreale GC; Bonfrate L; Portincasa P; Vincenzi M; Cottone C; Ormando VM; Scalise N; Lawson PF; Burattini O; Montale A; Luzza F; Rossi M; Vanni R; Bozzi R; Vincoli G; Stefani N; Borghi C; Vaira D
    Minerva Gastroenterol (Torino); 2023 Mar; 69(1):123-127. PubMed ID: 36856276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of purified clinoptilolite-tuff treatment in patients with irritable bowel syndrome with diarrhea: Randomized controlled trial.
    Anderle K; Wolzt M; Moser G; Keip B; Peter J; Meisslitzer C; Gouya G; Freissmuth M; Tschegg C
    World J Gastroenterol; 2022 Dec; 28(46):6573-6588. PubMed ID: 36569277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of two natural medicine formulations on irritable bowel syndrome symptoms: a pilot study.
    Hawrelak JA; Myers SP
    J Altern Complement Med; 2010 Oct; 16(10):1065-71. PubMed ID: 20954962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and dose response of
    Martoni CJ; Srivastava S; Damholt A; Leyer GJ
    World J Gastroenterol; 2023 Jul; 29(28):4451-4465. PubMed ID: 37576702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of irritable bowel syndrome.
    Trinkley KE; Nahata MC
    J Clin Pharm Ther; 2011 Jun; 36(3):275-82. PubMed ID: 21545610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double-blind, placebo-controlled, multicenter, phase II trial.
    Choi CH; Kwon JG; Kim SK; Myung SJ; Park KS; Sohn CI; Rhee PL; Lee KJ; Lee OY; Jung HK; Jee SR; Jeen YT; Choi MG; Choi SC; Huh KC; Park H
    Neurogastroenterol Motil; 2015 May; 27(5):705-16. PubMed ID: 25809913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Irritable bowel syndrome in the Russian Federation: results of the ROMERUS multicenter observational study].
    Maev IV; Okhlobystina OZ; Khalif IL; Andreev DN
    Ter Arkh; 2023 Feb; 95(1):38-51. PubMed ID: 37167114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome.
    Ishaque SM; Khosruzzaman SM; Ahmed DS; Sah MP
    BMC Gastroenterol; 2018 May; 18(1):71. PubMed ID: 29801486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Peppermint Oil in a Randomized, Double-Blind Trial of Patients With Irritable Bowel Syndrome.
    Weerts ZZRM; Masclee AAM; Witteman BJM; Clemens CHM; Winkens B; Brouwers JRBJ; Frijlink HW; Muris JWM; De Wit NJ; Essers BAB; Tack J; Snijkers JTW; Bours AMH; de Ruiter-van der Ploeg AS; Jonkers DMAE; Keszthelyi D
    Gastroenterology; 2020 Jan; 158(1):123-136. PubMed ID: 31470006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Probiotics for Irritable Bowel Syndrome: A Systematic Review and Network Meta-Analysis.
    Zhang T; Zhang C; Zhang J; Sun F; Duan L
    Front Cell Infect Microbiol; 2022; 12():859967. PubMed ID: 35433498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of probiotics, prebiotics and synbiotics in irritable bowel syndrome: a systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials.
    Zhang WX; Shi LB; Zhou MS; Wu J; Shi HY
    J Med Microbiol; 2023 Sep; 72(9):. PubMed ID: 37772692
    [No Abstract]   [Full Text] [Related]  

  • 12. Probiotics, prebiotics, and low FODMAP diet for irritable bowel syndrome - What is the current evidence?
    Ooi SL; Correa D; Pak SC
    Complement Ther Med; 2019 Apr; 43():73-80. PubMed ID: 30935559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supplementation with a lecithin-based delivery form of Boswellia serrata extract (Casperome®) controls symptoms of mild irritable bowel syndrome.
    Belcaro G; Gizzi G; Pellegrini L; Corsi M; Dugall M; Cacchio M; Feragalli B; Togni S; Riva A; Eggenhoffner R; Giacomelli L
    Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2249-2254. PubMed ID: 28537656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partially hydrolyzed guar gum in pediatric functional abdominal pain.
    Romano C; Comito D; Famiani A; Calamarà S; Loddo I
    World J Gastroenterol; 2013 Jan; 19(2):235-40. PubMed ID: 23345946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptom Severity Following Rifaximin and the Probiotic VSL#3 in Patients with Chronic Pelvic Pain Syndrome (Due to Inflammatory Prostatitis) Plus Irritable Bowel Syndrome.
    Vicari E; Salemi M; Sidoti G; Malaguarnera M; Castiglione R
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29099760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symbiotics in irritable bowel syndrome--better than probiotics alone?
    Gracie DJ; Ford AC
    Curr Opin Clin Nutr Metab Care; 2015 Sep; 18(5):485-9. PubMed ID: 26107141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary interventions for recurrent abdominal pain in childhood.
    Newlove-Delgado TV; Martin AE; Abbott RA; Bethel A; Thompson-Coon J; Whear R; Logan S
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010972. PubMed ID: 28334433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probiotics and prebiotics in the management of irritable bowel syndrome: a review of recent clinical trials and systematic reviews.
    Whelan K
    Curr Opin Clin Nutr Metab Care; 2011 Nov; 14(6):581-7. PubMed ID: 21892075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of irritable bowel syndrome. A case control experience.
    Astegiano M; Pellicano R; Terzi E; Simondi D; Rizzetto M
    Minerva Gastroenterol Dietol; 2006 Dec; 52(4):359-63. PubMed ID: 17108865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the clinical efficacy of linaclotide in irritable bowel syndrome with constipation.
    Johnston JM; Shiff SJ; Quigley EM
    Curr Med Res Opin; 2013 Feb; 29(2):149-60. PubMed ID: 23198977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.